Table 1.
Deduced amino acid sequences of paired TCR α- and β-chains of microdissected T cells from muscle biopsy tissue
Patient | Chain and sequence |
No. of cells with TCR identified by |
|||||
---|---|---|---|---|---|---|---|
V | N(D)N | J | Universal primer set | Clone-specific primer | |||
PM16488 (1,230 cells analyzed) | |||||||
β-Chain | 1.1 | CASSV | GGL | YGYTF | 1.2 | 64 | |
α-Chains | 2.2 | CAM | SQGAQKLVF | 54 | 6 | 20 | |
11.1 | CAV | GS | NARLMF | 31 | 1 | 1 | |
20.1 | CL | LSS | NTGKLIF | 37 | 1 | 1 | |
23.1 | CAV | D | SGTYKYIF | 40 | 1 | 1 | |
IBM15551 (250 cells analyzed) | |||||||
β-Chain | 23.1 | CASS | SDRE | NTEAFF | 1.1 | 8 | |
α-Chains | 4.2 | CI | ASV | YGNKLVF | 47 | 1 | 1 |
23.1 | CA | VL | NAGNMLTF | 39 | 1 | 1 |
In a first step, we detected TCR β-chain sequences of expanded clones by CDR3 spectratyping. The deduced amino acid sequences are shown. Then, biopsy sections were stained by appropriate anti-Vβ antibodies, and Vβ-positive cells were isolated by microdissection. We tested these cells for the expression of the correct, expanded TCR β-chains by single-cell PCR using clone-specific primers. We identified 64 cells from patient PM16488 and 8 cells from patient IBM15551 that had identical sequences as determined by CDR3 spectratyping and single-cell PCR. These β-chain-positive cells were then tested for α-chain expression by using a universal primer set that allows amplification of all possible TCR α-chains. The sequences of the α-chains and the numbers of cells identified are listed. Based on the sequences of these α-chains, all β-chain-positive cells were reexamined for α-chains by using clone-specific α-primers. In all cells in which we had identified an α-chain with the universal primer set, we confirmed expression of this α-chain with clone-specific primers. In patient PM16488, we identified the Vα2.2-Jα54 sequence in 14 additional cells.